Prevencio's AI-driven HART CVE Blood Test Demonstrates Usefulness in Spinal Cord Injury Patients
Prevencio’s AI-driven HART CVE Blood Test Demonstrates Usefulness in Spinal Cord Injury Patients
Stay updated with breaking news from Proprietary Algorithms. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Prevencio’s AI-driven HART CVE Blood Test Demonstrates Usefulness in Spinal Cord Injury Patients
Prevencio’s AI-driven HART CVE Blood Test Demonstrates Usefulness in Spinal Cord Injury Patients
NEW YORK, June 09, 2021 (GLOBE NEWSWIRE) -- PainQx, Inc. (www.painqx.com), a medical device company developing a next-generation approach to objectively assess chronic pain, is pleased to announce it has been awarded a Defense Health Agency (www.health.mil) Phase II SBIR contract. The DHA SBIR contract will enable PainQx to refine and expand the capabilities of its novel pain assessment technology, the ALGOS System. The PainQx ALGOS System is an AI-enabled software platform that uses electroence
Press release content from Business Wire. The AP news staff was not involved in its creation. Prevencio Announces Laboratory Commercialization Partnership with Atlas Genomics Incorporating Microsoft’s AI-computing Cloud April 21, 2021 GMT KIRKLAND, Wash.--(BUSINESS WIRE)--Apr 21, 2021-- Prevencio, Inc. today announces an Agreement with Atlas Genomics to commercially launch its highly accurate, AI-driven HART blood tests for heart disease and risk of heart attack, stroke, and cardiovascular death. The HART blood tests are now available and can be ordered through your physician. Atlas Genomic...